Saturday, October 31, 2026

Alamos Gold Inc Ordinary Shares And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 17, 2020

Alamos Gold Inc Ordinary Shares And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. ServiceNow

24.3% sales growth and 34.15% return on equity

ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide.

ServiceNow's sales growth this year is expected to be 29.7% and 24.9% for next year.

Year-on-year quarterly revenue growth grew by 30%, now sitting on 4.22B for the twelve trailing months.

ServiceNow's sales growth for the next quarter is 24.3%. The company's growth estimates for the current quarter and the next is 10.4% and 20%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.15%.

ServiceNow's Stock Yearly Top and Bottom Value

ServiceNow's stock is valued at $545.00 at 07:22 EST, below its 52-week high of $549.88 and way higher than its 52-week low of $238.93.

ServiceNow's Moving Average

ServiceNow's worth is above its 50-day moving average of $516.03 and way higher than its 200-day moving average of $463.64.

2. Catalent, Inc.

22.5% sales growth and 10.21% return on equity

Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide.

Catalent, Inc.'s sales growth this year is expected to be 20.2% and 9.9% for next year.

Year-on-year quarterly revenue growth grew by 27.2%, now sitting on 3.28B for the twelve trailing months.

Catalent, Inc.'s sales growth is a negative 0% for the ongoing quarter and 22.5% for the next. The company's growth estimates for the present quarter and the next is 24.4% and 28%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.21%.

Catalent, Inc.'s Stock Yearly Top and Bottom Value

Catalent, Inc.'s stock is valued at $95.93 at 07:22 EST, way below its 52-week high of $120.48 and way higher than its 52-week low of $31.04.

Catalent, Inc.'s Moving Average

Catalent, Inc.'s value is below its 50-day moving average of $96.95 and way above its 200-day moving average of $86.32.

3. Alamos Gold Inc Ordinary Shares

25.3% sales growth and 3.88% return on equity

Alamos Gold Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and extraction of gold deposits in North America.

Alamos Gold Inc Ordinary Shares's sales growth this year is anticipated to be 18.2% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 707.5M for the twelve trailing months.

Alamos Gold Inc Ordinary Shares's sales growth for the next quarter is 25.3%. The company's growth estimates for the present quarter and the next is 600% and 25%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.88%.

Alamos Gold Inc Ordinary Shares's Stock Yearly Top and Bottom Value

Alamos Gold Inc Ordinary Shares's stock is valued at $9.09 at 07:22 EST, way below its 52-week high of $11.58 and way higher than its 52-week low of $3.34.

Alamos Gold Inc Ordinary Shares's Moving Average

Alamos Gold Inc Ordinary Shares's worth is above its 50-day moving average of $8.83 and below its 200-day moving average of $9.27.

4. Quidel Corporation

443.6% sales growth and 53.6% return on equity

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.

Quidel Corporation's sales growth this year is anticipated to be 210.6% and 91.4% for next year.

Year-on-year quarterly revenue growth grew by 276.4%, now sitting on 1B for the twelve trailing months.

Quidel Corporation's sales growth for the next quarter is 443.6%. The company's growth estimates for the ongoing quarter and the next is 907% and 941%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 53.6%.

Quidel Corporation's Stock Yearly Top and Bottom Value

Quidel Corporation's stock is valued at $202.56 at 07:22 EST, way under its 52-week high of $306.72 and way higher than its 52-week low of $68.66.

Quidel Corporation's Moving Average

Quidel Corporation's value is under its 50-day moving average of $215.47 and under its 200-day moving average of $218.74.

5. Power Integrations, Inc.

19% sales growth and 30.06% return on equity

Power Integrations, Inc. designs, develops, manufactures, and markets analog and mixed-signal integrated circuits (ICs), and other electronic components and circuitry used in high-voltage power conversion worldwide.

Power Integrations, Inc.'s sales growth this year is anticipated to be 11.1% and 12.7% for next year.

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 452.08M for the twelve trailing months.

Power Integrations, Inc.'s sales growth for the next quarter is 19%. The company's growth estimates for the ongoing quarter and the next is 7.3% and 13.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.06%.

Power Integrations, Inc.'s Stock Yearly Top and Bottom Value

Power Integrations, Inc.'s stock is valued at $72.76 at 07:22 EST, below its 52-week high of $77.65 and way higher than its 52-week low of $38.57.

Power Integrations, Inc.'s Moving Average

Power Integrations, Inc.'s worth is above its 50-day moving average of $68.08 and way higher than its 200-day moving average of $60.39.

6. First Horizon National Corporation

61% sales growth and 11.16% return on equity

First Horizon National Corporation operates as the bank holding company for First Horizon Bank that provides various financial services.

First Horizon National Corporation's sales growth this year is anticipated to be 51.7% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 1.94B for the twelve trailing months.

First Horizon National Corporation's sales growth for the next quarter is 61%. The company's growth estimates for the ongoing quarter and the next is a negative 29.8% and 540%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.16%.

First Horizon National Corporation's Stock Yearly Top and Bottom Value

First Horizon National Corporation's stock is valued at $12.96 at 07:22 EST, way below its 52-week high of $17.40 and way above its 52-week low of $6.27.

First Horizon National Corporation's Moving Average

First Horizon National Corporation's value is above its 50-day moving average of $11.80 and way higher than its 200-day moving average of $10.27.

7. Lakeland Industries, Inc.

17.1% sales growth and 28.75% return on equity

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide.

Lakeland Industries, Inc.'s sales growth this year is anticipated to be 37.7% and a negative 11.8% for next year.

Year-on-year quarterly revenue growth grew by 50.9%, now sitting on 150.24M for the twelve trailing months.

Lakeland Industries, Inc.'s sales growth for the next quarter is 17.1%. The company's growth estimates for the ongoing quarter and the next is 193.3% and negative -72%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.75%.

Lakeland Industries, Inc.'s Stock Yearly Top and Bottom Value

Lakeland Industries, Inc.'s stock is valued at $22.28 at 07:22 EST, way below its 52-week high of $28.00 and way higher than its 52-week low of $10.45.

Lakeland Industries, Inc.'s Moving Average

Lakeland Industries, Inc.'s worth is above its 50-day moving average of $21.21 and above its 200-day moving average of $21.33.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com